Video News; Scythian Biosciences (TSX.V: $SCYB.V) Discusses #Cannabinoid-based Treatment for #Concussion and Traumatic Brain Injury

Video News; Scythian Biosciences (TSX.V: $SCYB.V) Discusses #Cannabinoid-based Treatment for #Concussion and Traumatic Brain Injury

August 18, 2017 – Investorideas.com, a global news source and investor resource covering cannabis and biotech stocks releases a video/ interview featuring David Schrader, Chief Operating Officer of Scythian Biosciences (TSX.V: SCYB), a company developing a drug regimen for concussion and traumatic brain injury using a cannabinoid-based combination drug therapy.

Watch video: https://www.youtube.com/watch?v=DaNLaGh0G-w

Read this news in full athttp://www.investorideas.com/CO/SCYB/news/2017/08181Video.asp

Scythian ( http://scythianbio.com/) is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination. 

Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen.  The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem.  The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities.   

Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami.  Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation.  She has extensive experience in neurocognitive testing.  Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995. 

Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.

About Investorideas.com - News that Inspires Big Ideas

www.Investorideas.com  is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Listen to original podcast:http://www.investorideas.com/CO/SCYB/news/2017/08161COOTalks.asp

The Investorideas.com podcasts are also available on iTunes, Tunein, Sticher. Spreaker.com, iHeart.com  and Google Play Music.

Visit the Podcast page at Investorideas.com: http://www.investorideas.com/Audio/

Subscribe to Investorideas.com Podcast RSS:

http://www.investorideas.com/rss/feeds/Podcasts.xml

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details -http://www.investorideas.com/About/News/Clientspecifics.asp

Visit Scythian Biosciences (TSX.V: SCYB  )Profile page:http://www.investorideas.com/CO/SCYB/

Contact Investorideas.com

800-665-0411

Scythian Biosciences Corp. (TSXV: $SCYB.V) Retains Hybrid Financial Ltd. for Investor Relations Activities

Scythian Biosciences Corp. (TSXV: $SCYB.V) Retains Hybrid Financial Ltd. for Investor Relations Activities

TORONTO - August 17, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) announces that it has retained the services of Hybrid Financial Ltd. ("Hybrid Financial") for strategic investor relations activities. The initiatives includes marketing and investor relations services for the Company.

Read this news in full at http://www.investorideas.com/CO/SCYB/news/2017/08171InvestorRelations.asp

About Scythian Biosciences Corp.

Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.

Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities.

Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami. Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in neurocognitive testing. Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995.

Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.

Scythian Biosciences Corp. (TSX.V: SCYB)

is a Featured biotech and marijuana company on Investorideas.com

Visit Profile page: http://www.investorideas.com/CO/SCYB/

Get News Alerts on Scythian Biosciences Corp.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Pershing Gold (NASDAQ: $PGLC) (TSX: $PGLC.TO) New Website Showcases Preliminary Feasibility Study (PFS) for the Company's Relief Canyon Gold Mine

Pershing Gold (NASDAQ: $PGLC) (TSX: $PGLC.TO) New Website Showcases Preliminary Feasibility Study (PFS) for the Company's Relief Canyon Gold Mine

Point Roberts, WA, Delta BC –August 17, 2017 

(www.investorideas.com newswire) Investorideas.com, a global news source covering leading sectors including mining stocks announces Pershing Gold Corporation (NASDAQ:PGLC) (TSX:PGLC) (FWB:7PG1),an emerging Nevada gold producer has launched a new websitewww.PershingGold.com to showcase the robust economics evidenced in the recently released PFS for the Company's Relief Canyon Gold Mine.

Read this news in full at

http://www.investorideas.com/CO/PGLC/news/2017/08171PFS.asp

Additionally the company website features the June investor presentation at:

http://www.pershinggold.com/Cache/1500100825.PDF?O=PDF&T=&Y=&D=&FID=1500100825&iid=4353299

Table 1: Relief Canyon PFS Highlights

	PEA	PFS	Company Model
Life of mine (“LOM”)	5.8 years	5.6 years	5.6 years
Average LOM production	88,500 oz Au/year	93,900 oz Au/year	97,100 oz Au/year
Cash Cost	$772/oz Au	$770/oz Au	$769/oz Au
All in Sustaining Cost (“AISC”)	$804/oz Au	$802/oz Au	$801/oz Au
Initial capital expenditure (“CAPEX”)	$12.2 million	$23.6 million	$23.6 million
Sustaining CAPEX	$16.6 million	$22.8 million	$22.8 million
Pre-tax Net Present Value (“NPV”), 5%	$159 million	$145 million	$151 million
Pre-tax Internal Rate of Return (“IRR”)	125%	89%	91%
Pre-tax Net Cash Flow	$206 million	$192.7 million	$201 million
After-tax NPV, 5%	$121 million	$126 million	$131 million
After-tax IRR	109%	85%	87%
After-tax Net Cash Flow	$157.6 million	$167.7 million	$174.1 million

Table 2: PFS Gold Price Sensitivity Analysis, Before Tax

Gold Price / oz Au	PFS Plan NPV, 5%	PFS IRR	Company Plan NPV, 5%	Company Plan IRR
$1,450	$226 million	140%	$232 million	141%
$1,400	$206 million	127%	$212 million	129%
$1,350	$185 million	114%	$192 million	116%
$1,300	$165 million	102%	$171 million	103%
$1,250	$145 million	89%	$151 million	91%
$1,200	$124 million	77%	$131 million	79%
$1,150	$104 million	65%	$110 million	67%
$1,100	$84 million	53%	$90 million	55%

About Pershing Gold Corporation www.PershingGold.com

Pershing Gold is an emerging gold producer whose primary asset is the Relief Canyon Mine in Pershing County, Nevada. Relief Canyon includes three historic open-pit mines and a state-of-the-art, fully permitted and constructed heap-leach processing facility. Pershing Gold is currently permitted to resume mining at Relief Canyon under the existing Plan of Operations.

Pershing Gold's landholdings cover approximately 25,000 acres that include the Relief Canyon Mine asset and lands surrounding the mine in all directions. This land package provides Pershing Gold with the opportunity to expand the Relief Canyon Mine deposit and to explore and make new discoveries on nearby lands.

Pershing Gold Corporation (NASDAQ:PGLC) (TSX: PGLC) is a featured mining company on Investorideas.com: Visit company profile http://www.investorideas.com/CO/PGLC/

About Investorideas.com - News that Inspires Big Ideas www.investorideas.com
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Sectors we cover in include tech, bitcoin and blockchain , biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security including biometrics, Latin America, sports, entertainment, luxury brands and gaming.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.aspDisclosure: Pershing Gold Corporation (NASDAQ: PGLC) (TSX: PGLC) is a paid PR, media and news client more infohttp://www.investorideas.com/About/News/Clientspecifics.asp

Contact Investorideas.com

800 665 0411

Investor Ideas Updates Artificial Intelligence (AI) and Robotics Stock Directory

Investor Ideas Updates Artificial Intelligence (AI) and Robotics Stock Directory

Global artificial intelligence market expected to reach USD 35,870.0 million by 2025

August 17, 2017 – ( www.investorideas.com newswire) Investorideas.com, a global news source covering leading sectors including technology releases its updated stock directory for Artificial Intelligence (AI) and Robotics  stocks.

Read this news in full at http://www.investorideas.com/news/2017/artificial-intelligence/08171StockDirectory.asp

Hear the Podcast Interview: 

http://www.investorideas.com/Audio/Podcasts/062217-GOPH.mp3

Artificial Intelligence (AI) and Robotics Stocks

Featured AI stock

About Gopher Protocol Inc.

Gopher Protocol Inc. (OTCQB: GOPH) (http://gopherprotocol.com/) is a development-stage company which consider itself Native IoT creator, developing  Internet of Things (IoT) and Artificial Intelligence enabled mobile technology.  The Company has a portfolio of Intellectual Property that when commercialized will include smart microchips, mobile application software and supporting cloud software.  The system contemplates the creation of a global network.  Gopher believes this will be the first system that is developed using artificial intelligence based analysis engine.  The core of the system will be its advanced microchip technology that can be installed in any mobile device worldwide, Gopher envisions an internal, private network between all enabled mobile devices providing shared processing, advanced mobile database management/sharing and enhanced mobile features.

Corporate Site: http://gopherprotocol.com

Guardian Patch: http://www.guardianpatch.com/.

About Guardian Pet Tracker http://www.guardianpettracker.com/

The Guardian Pet Tracker system is a derivative technology of Gopher's Guardian Patch technology. The Sphere is designed to provide its users with local tracking capability using a re-chargeable/replaceable battery source. Not only does Guardian locate your pets on a wider radius than anyone else it does it without the need for Cellular Signal.  This way your pets always come home!

See the full list online http://www.investorideas.com/TSS/stock_list.asp#Robotics

About Investorideas.com - News that Inspires Big Ideas  www.investorideas.com
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Sectors we cover in include tech, bitcoin and blockchain , biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security including biometrics, Latin America, sports, entertainment, luxury brands and gaming.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution,social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Disclosure : Disclosure: GOPH is a PR , social media and publishing client and compensates Investorideas.com (effective April 4, 2016 - More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com

800 665 0411

TechSectorStocks.com - investing ideas in tech stocks - mobile payments, social media, AI and Robotics, Drone Stocks, GPS, Internet of Things (IoT)

Like Tech Stocks? View our Tech Stocks Directory  Get News Alerts on Tech Stocks

COO of Scythian Biosciences (TSX.V: $SCYB.V) Talks about Treatment for #Concussion and traumatic brain injury with #Cannabinoid-based combination drug therapy

COO of Scythian Biosciences (TSX.V: $SCYB.V) Talks about Treatment for #Concussion and traumatic brain injury with  #Cannabinoid-based combination drug therapy

August 16, 2017 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource covering cannabis and biotech stocks issues a  podcast interview with David Schrader, Chief Operating Officer at Scythian Biosciences Corp. (TSXV: SCYB).

Listen to the full podcast interview :

http://www.investorideas.com/Audio/Podcasts/081417-Scythian-Interview.mp3

Read this news in full at

http://www.investorideas.com/CO/SCYB/news/2017/08161COOTalks.asp

Scythian ( http://scythianbio.com/)  is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination. 

Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen.  The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem.  The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities.   

Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami.  Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation.  She has extensive experience in neurocognitive testing.  Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995. 

Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.

About Investorideas.com - News that Inspires Big Ideas

www.Investorideas.com  is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

The Investorideas.com podcasts are also available on iTunes, Tunein, Sticher. Spreaker.com, iHeart.com  and Google Play Music.

Visit the Podcast page at Investorideas.com: http://www.investorideas.com/Audio/

Subscribe to Investorideas.com Podcast RSS:

http://www.investorideas.com/rss/feeds/Podcasts.xml

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details -http://www.investorideas.com/About/News/Clientspecifics.asp

Visit Profile page: http://www.investorideas.com/CO/SCYB/

Contact Investorideas.com

800-665-0411